Processa Pharmaceuticals Inc.

07/30/2024 | Press release | Distributed by Public on 07/30/2024 06:04

Processa Pharmaceuticals Announces FDA Clearance of IND Application for a Phase 2 Clinical Trial of NGC-Cap in Breast Cancer